# Everything You Need to Know About Hantavirus: What the Cruise Ship Outbreak Means > Published on ADIN (https://adin.chat/s/a-deadly-virus-is-spreading-on-a-cruise-ship-it-is-not-the-one-youre-thinking-of) > Type: Article > Date: 2026-05-07 > Description: On March 20, passengers boarded the MV Hondius in Ushuaia, Argentina, for an expedition cruise through the South Atlantic bound for the Canary Islands. By early May, at least seven of them had contracted hantavirus. The ship was moored off Praia, Cape Verde, while international health authorities... On March 20, passengers boarded the MV Hondius in Ushuaia, Argentina, for an expedition cruise through the South Atlantic bound for the Canary Islands. By early May, at least seven of them had contracted hantavirus. The ship was moored off Praia, Cape Verde, while international health authorities tracked the outbreak. The World Health Organization had not ruled out person-to-person transmission -- a development scientists described as extremely rare and, if confirmed, significant. The Africa CDC issued a formal monitoring statement. Major news organizations published alerts. The disease spreading aboard the Hondius kills between 35 and 40 percent of the people it infects in the United States, according to the CDC. There is no approved antiviral treatment for it. There is no approved vaccine. Most people have heard of hantavirus only in passing, if at all -- a footnote to the pandemic era, a word that surfaced briefly in 2020 and then receded. The cruise ship outbreak has returned it to the foreground, and with it a set of questions that the past five years have made familiar: how this virus compares to the one that reshaped daily life in 2020, what is actually understood about it, and what the current outbreak means. ## What Hantavirus Is Hantavirus is not a single pathogen. It is a family of viruses -- formally reclassified in recent years as orthohantaviruses -- carried by rodents and transmitted to humans primarily through contact with infected animals or their urine, droppings, and saliva. More than 50 distinct strains have been identified globally, each associated with a specific rodent host species. The two disease presentations they produce differ significantly by geography: - **Hantavirus pulmonary syndrome (HPS)** -- the dominant form in the Americas, caused primarily by Sin Nombre virus, first identified in 1993 after unexplained deaths among healthy young adults in the Four Corners region of the southwestern United States. It progresses from fever and muscle aches to fluid accumulation in the lungs within days. Case fatality rate: 35 to 40 percent in the United States. - **Hemorrhagic fever with renal syndrome (HFRS)** -- the dominant form in Asia and Europe, caused by strains including Hantaan and Seoul virus. It targets the kidneys rather than the lungs. Case fatality rate: 1 to 15 percent depending on strain, though permanent kidney damage is documented in survivors. Management of both conditions is supportive. Ribavirin has shown benefit in HFRS cases when administered early, but evidence for its use in pulmonary cases remains limited. Patients who reach the critical phase of HPS require: - Oxygen therapy and precise fluid management - Mechanical ventilation in severe respiratory failure - Extracorporeal membrane oxygenation, in the most critical cases, to maintain circulation while the lungs are compromised ## What Coronavirus Is SARS-CoV-2, the coronavirus responsible for Covid-19, belongs to an entirely different viral family -- Coronaviridae -- and operates through a different biological mechanism. Hantavirus is carried by rodents and reaches humans through environmental contact with infected material. SARS-CoV-2 spreads through airborne droplets and aerosols produced when an infected person breathes, speaks, or coughs. The two viruses attack different systems. Hantavirus targets either the pulmonary vasculature or the kidneys, depending on strain. SARS-CoV-2 binds to ACE2 receptors distributed throughout the body -- lungs, heart, blood vessels, gastrointestinal tract -- producing disease that ranges from mild respiratory illness to severe multi-organ involvement. The most consequential difference, from a public health standpoint, is transmission. SARS-CoV-2 spreads efficiently between people with a relatively long pre-symptomatic infectious window -- the combination that allowed it to seed global spread in weeks. Hantavirus, in its currently understood form, does not. An infected person is not a transmission risk to those around them. The chain of transmission ends with the human case. The virus kills a substantial fraction of the people it infects but has never produced pandemic spread because it lacks a mechanism for finding new hosts efficiently. ## Where the Two Diseases Look Alike Severe hantavirus pulmonary syndrome and severe Covid-19 share enough clinical features to create genuine diagnostic difficulty early in an illness, which is why the CDC published a clinical comparison of the two conditions in the early months of the pandemic. Shared presentations include: - Fever and fatigue at onset - Progressive respiratory distress requiring supplemental oxygen or mechanical ventilation - Fluid accumulation in the lungs - Risk of rapid deterioration into critical illness The differentiating factors are exposure history and speed. Recent contact with rodents or rodent-infested environments -- camping, working in outbuildings, cleaning spaces with rodent nesting activity -- is a significant clinical indicator for hantavirus. HPS also tends to compress the timeline from symptom onset to respiratory crisis more severely than Covid-19 pneumonia, leaving a narrower window for intervention. ## The Cruise Ship Investigation The MV Hondius cases initially appeared consistent with established transmission patterns. The ship's itinerary included Patagonia and other regions of South America where rodent-borne hantavirus exposure is well documented. Passengers with probable rodent contact during shore excursions in Argentina contracting the virus independently would represent an unusual but not unprecedented cluster of cases. What elevated international concern was the WHO's position that person-to-person transmission among some passengers could not be ruled out. A small number of human-to-human transmission events have been documented previously, primarily involving Andes virus -- a South American strain, and the one most likely circulating among the Hondius passengers. None of those prior events produced sustained chains of infection beyond immediate contacts. As of this writing, the WHO has not confirmed human-to-person transmission in the Hondius outbreak. Epidemiologists have noted that passengers who visited the same shore locations in Argentina may have had similar environmental exposures, making independent rodent contact a more parsimonious explanation for clustered cases than a novel transmission event. The investigation continues. ## What the Pandemic Risk Question Actually Involves Pandemic potential requires three conditions to align simultaneously: a pathogen lethal enough to produce meaningful mortality at scale, efficient transmission between people, and a large susceptible population with no prior immunity. SARS-CoV-2 in early 2020 met all three. Hantavirus, as currently understood, meets only the first -- and decisively so. The case fatality rate for hantavirus pulmonary syndrome runs roughly 10 times higher than early estimates of Covid-19's infection fatality rate in unvaccinated populations. The scientific consensus holds that sustained human-to-human spread is unlikely -- that the biological architecture of the virus, including its dependence on rodent intermediate hosts and the absence of established respiratory transmission mechanisms, presents a fundamental barrier. That consensus could be revised. Viruses mutate, and the emergence of Sin Nombre in 1993 was itself a surprise -- a previously unidentified pathogen producing clusters of deaths eventually traced to a deer mouse population explosion following unusual rainfall in the Southwest. Scientists monitor the hantavirus family as a direct consequence of that history. ## Reducing Exposure The primary vector is environmental. Exposure typically occurs through disturbing areas of rodent activity in regions with established populations across North America, South America, Europe, and Asia. High-risk scenarios include: - Cleaning barns, sheds, or cabins with accumulated rodent droppings or nesting material - Camping in areas with deer mouse or other rodent activity - Handling live or dead rodents without protective equipment - Disturbing dry rodent droppings by sweeping, which can aerosolize infectious particles The CDC advises wetting contaminated surfaces with a disinfectant solution before cleaning, using gloves and respiratory protection during any cleanup involving rodent material, and sealing entry points to homes and outbuildings as the primary structural mitigation. For travelers to Patagonia and other South American regions with documented hantavirus circulation, awareness of rodent exposure during outdoor activities is the primary precaution. There is no pre-exposure prophylaxis and no approved vaccine. ## What Comes Next The Hondius will dock. The investigation will reach its conclusions. The passengers who contracted hantavirus face odds that the disease's fatality rate makes sobering regardless of where they received care. The virus itself will remain where it has always been -- in the rodent populations that carry it across four continents, transmitted to humans through incidental contact that has produced small clusters and isolated fatalities for decades without ever finding a pathway to the kind of spread that defines a pandemic. Whether that remains true depends on factors that surveillance systems exist to detect and that the current investigation aboard a cruise ship in the Atlantic is, in its way, helping to monitor.